The emergence of antimicrobial resistance and the persistence of Klebsiella pneumoniae biofilms represent significant challenges to public health. Hermetia illucens (HI) larvae are considered a sustainable reservoir of novel bioactive compounds. This protocol details a method for extracting fatty acids from HI larvae fat (AWME3 fraction) and studying their effects on multidrug-resistant and hypervirulent Klebsiella pneumoniae strains. Effects are evaluated by crystal violet and ethidium bromide uptake assays, motility assays (swimming, swarming, and twitching), minimal biofilm inhibitory and eradication concentration tests (MBIC/MBEC) for single, mixed, and mature biofilms, light, fluorescence, and scanning electron microscopy imaging, and microbial adhesion to solvents (MATS). This protocol offers a reliable methodology for evaluating the anti-biofilm and anti-virulence properties of natural compounds.